Stocks › Biotechnology › VALN

Valneva VALN

US equityMarket cap rank #3672Biotechnology

$5.87 +$0.01 (+0.17%)

Pre-market · Oct 8, 7:00 am ET · After hours $5.61 -4.43%

Open$5.87

Prev close$5.86

Day range$5.87 – $5.99

Volume26.3K

Market cap$556.61M

P/E (TTM)–

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership35.8%-0.99 pts vs. prior quarter

Institutions holding63-1 vs. prior quarter

Short interest0.20% of floatDays to cover 4.8 · as of 15 Sep 2026

Short-sale volume share12.6%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$110.2K (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 20.6% of shares outstanding.

Largest holders

Pfizer Venture Investments LLC5.04%
Frazier Life Sciences Management, LP4.35%
The Goldman Sachs Group, Inc.4.13%
Bpifrance Participations SA3.77%
Groupe Grimaud La Corbière SA3.30%
Braidwell LP2.85%
CDC Croissance2.51%
Candriam, Société En Commandite Par Actions1.82%

By investor type

VC/PE Fund13.97%
Mutual Fund10.04%
Public Company4.27%
Private Company3.49%
Hedge Fund3.30%
Individual/Insider1.31%
Sovereign Wealth Fund0.68%
Family Office/Trust0.01%

Reported short interest has held roughly steady near 0.20% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	191,759	0.2%	4.8
31 Aug 2026	194,066	0.2%	4.5
14 Aug 2026	160,474	0.2%	1.0
31 Jul 2026	158,672	0.2%	7.8
15 Jul 2026	165,539	0.2%	6.1
30 Jun 2026	182,102	0.2%	8.4

Discussion

No comments yet — be the first to weigh in on VALN.